Skip To Content

Orthodox Scientist Develops ‘MonitHer’ To Detect Breast Cancer At Home

Image by iStock

A handheld ultrasound is being developed so that women can monitor their own breasts at home, allowing for a speedier detection of breast cancer.

The brains behind the product, Orthodox Jew Yehudit Abrams, is a former biomedical scientist at NASA, but has changed gears in her career to focus on the software of this product, which could revolutionize the detection of breast cancer at a much earlier point than has been possible previously. She is now focusing on her newly formed company ‘MonitHer’ to develop the product.

The ultrasound device is devised to be used at home by women once a month to detect any changes made to their breasts. The information from the ultrasound is translated onto an app, which then tracks the development and any changes made. From the app, the data is then transmitted to the cloud, where the images will be compared to thousands of other images of breast pathologies.

Image by Israel 21C

Abram said in an interview with “The Times of Israel”, “The moment the software identifies pathological changes in breast tissue, the app notifies the user, and the user can then send, via a secured link, historical images of the breast region in question directly to their physician for review.”

Although it could take up to 3 years for the hardware of the product to be developed, the US Food and Drug Administration has already approved the patented software of the product, hopefully meaning that the forthcoming process will be as speedy as possible.

In the US, 1 in 8 women will develop invasive breast cancer at some point in their life, so the implications of such a groundbreaking piece of technology are undeniable. The ability to detect changes in your breasts from your own home creates for a much earlier diagnosis, thus increasing the chances of successful treatment.

Nicola Lewis is a summer intern at the Forward, writing for the life section. You can reach her at [email protected]

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

Now more than ever, American Jews need independent news they can trust, with reporting driven by truth, not ideology. We serve you, not any ideological agenda.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and the protests on college campuses.

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

Make a gift of any size and become a Forward member today. You’ll support our mission to tell the American Jewish story fully and fairly. 

— Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.